Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

The study created a test that found hormonal and toxic effects in plant and fungal extracts using prostate cancer cells.

Topical minoxidil improves hair loss in 80% of women with breast cancer undergoing endocrine therapy.

Ki-67 levels do not predict treatment response in triple-negative breast cancer.

Scalp cooling helps prevent hair loss during certain breast cancer treatments, especially when anthracyclines aren't used.

Scalp cooling therapy helps preserve hair during chemotherapy for most patients.

Exosomes show promise for targeted treatment of HER2-positive breast cancer.

Kanglaite injection with chemotherapy improves treatment and reduces side effects for advanced lung cancer.

PDCD4 protein levels, affected by genetics and breastfeeding, may predict breast cancer treatment response.

Electromagnetic energy from wound dressing paste can disrupt skin lipid droplets, possibly affecting cancer development.

A woman with cervical cancer had rare scalp metastasis causing a unique type of hair loss.

YH0618 granule may help prevent hair loss in breast cancer patients undergoing chemotherapy.

DHL-HisZnNa may help reduce hair loss from chemotherapy, but more research is needed.

Kidney cancer cells without folliculin are more sensitive to radiation due to increased self-eating cell death.

Fasting may reduce chemotherapy side effects.

A specific gene variant is linked to a higher risk of hair loss from chemotherapy in breast cancer patients.

The lotion CG428 did not show effectiveness in treating permanent hair loss in breast cancer survivors.

Both scalp cooling and chemical cooling caps effectively prevent hair loss in breast cancer patients undergoing chemotherapy.

The treatment combination is safe and effective for some patients with this type of breast cancer.

Inactive hair follicle stem cells help prevent skin cancer.

The review found that different stem cell types in the skin are crucial for repair and could help treat skin diseases and cancer.

Removing integrin α3β1 from hair stem cells lowers skin tumor growth by affecting CCN2 protein levels.

Skin problems are common after stem cell transplants, and early treatment by dermatologists can improve patient outcomes.

Skin stem cells are crucial for maintaining and repairing skin, with potential for treating skin disorders and improving wound healing.

Blood tests for tumor cells could improve prostate cancer diagnosis and treatment; hair loss severity linked to a gene affecting prostate conditions.

Breast cancer hormone therapy can cause hair loss, which can be treated with daily applications of specific topical solutions like minoxidil and hydrocortisone butyrate.

Asian women with breast cancer experience the highest rates of long-term hair loss and related distress after chemotherapy.

Hair loss is a common, often overlooked side effect of hormone treatments for breast and prostate cancer.

Finasteride for hair loss may increase the risk of certain cancers and has side effects; better regulation and education on its use are needed.

Keratin 15 is not a reliable sole marker for identifying epidermal stem cells because it's found in various cell types.

Epidermal stem cells could lead to new treatments for skin and hair disorders.